Loading…
Reported covered position: Rep. Rick Allen 2015-2021, LA, LD; Rep. Morgan Griffith, 2011-2015, Staff Assistant, LC, LA
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WALMART INC · Firm: WALMART INC.
Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules
Ensuring Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164, Equitable Community Access to Pharmacist Services Act (ECAPS)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2025 · third_quarter · Q3
Discussions related to TSCA section 5 review process Discussions related to on-line marketplace compliance programs
Discussions in support of the Combating Organized Retail Crime Act
Source: Senate LDA
Ensuring Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to pharmacy and reimbursement
Financial Services and General Government Appropriations Act, 2026
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.5166, the Financial Services and General Government Appropriations Act, 2026
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to pharmacy and reimbursement
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to supply chain resilience
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS)
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS)
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions regarding pharmacy provider status legislation Discussions related to therapeutic equivalency standards for prescription drug offerings
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions on payment acceptance
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions regarding company's associate and consumer financial services offerings
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions opposing efforts to postpone Federal Reserve rulemaking, S.4570/H.R.7531, Secure Payments Act
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions opposing efforts to postpone Federal Reserve rulemaking, S.4570/H.R.7531, Secure Payments Act
Discussions regarding SHOP SAFE Act, H.R.8684
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions on payment acceptance
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions regarding company's associate and consumer financial services offerings
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions opposing efforts to postpone Federal Reserve rulemaking, S.4570/H.R.7531, Secure Payments Act
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions regarding pharmacy provider status legislation Discussions related to therapeutic equivalency standards for prescription drug offerings
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to supply chain resilience
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS)
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS)
Discussions regarding SHOP SAFE Act, S.2934
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions opposing efforts to postpone Federal Reserve rulemaking, S.4570/H.R.7531, Secure Payments Act
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act Discussions related to prescription drug affordability Discussions regarding Walmart's participation in the federal retail pharmacy vaccine administration program related to Covid-19 Discussions regarding Medicare reimbursement for telemedicine services
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act Discussions related to prescription drug affordability Discussions regarding Walmart's participation in the federal retail pharmacy vaccine administration program related to Covid-19 Discussions regarding Medicare reimbursement for telemedicine services
Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to pharmacy and reimbursement
Discussions regarding H.R.5166, the Financial Services and General Government Appropriations Act, 2026
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Executive Office of the President (EOP), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Maritime Administration (MARAD), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2025 · second_quarter · Q2
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions regarding trade enforcement actions and tariff proposals by the Administration
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules
Discussions on payment acceptance Discussions in support of S.Amdt.2345/S.Amdt.2229, the Credit Card Competition Act
Discussions in support of the Combating Organized Retail Crime Act
Discussions regarding H.R.3164, Equitable Community Access to Pharmacist Services Act (ECAPS)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Education, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2025 · first_quarter · Q1
Discussions related to corporate tax rate and revenue measures Discussions regarding international taxation: OECD Pillar II Model rules Discussions regarding tax extenders
Discussions in support of the Combating Organized Retail Crime Act
Discussions regarding Medicare coverage for pharmacy services
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2024 · fourth_quarter · Q4
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions regarding company's associate and consumer financial services offerings
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS)
Filing targets: Agriculture, Dept of (USDA), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, White House Office
2024 · third_quarter · Q3
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions regarding SHOP SAFE Act, H.R.8684
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS)
Discussions regarding support of Esther's Law Discussions regarding online marketplace compliance program
Discussions regarding corporate sustainability initiatives
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), White House Office
2024 · second_quarter · Q2
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding water beads product safety legislation
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions opposing efforts to postpone Federal Reserve rulemaking, S.4570/H.R.7531, Secure Payments Act
2024 · first_quarter · Q1
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to supply chain resilience
2023 · fourth_quarter · Q4
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding corporate sustainability initiatives
2023 · third_quarter · Q3
Discussions regarding U.S. manufacturing commitment and supply chain policy Discussions related to incentives for U.S. Manufacturing
Discussions regarding corporate sustainability initiatives
Discussions related to Walmart Marketplace policies
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions regarding pharmacy provider status legislation Discussions related to therapeutic equivalency standards for prescription drug offerings
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
Discussions regarding corporate sustainability initiatives
Discussions regarding online marketplace compliance program
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838) Discussions on payment acceptance
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions regarding SHOP SAFE Act, S.2934
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Federal Aviation Administration (FAA), Federal Energy Regulatory Commission (FERC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR)
Discussions in support of S.140/H.R.895, the Combating Organized Retail Crime Act of 2023
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act Discussions related to prescription drug affordability Discussions regarding Walmart's participation in the federal retail pharmacy vaccine administration program related to Covid-19 Discussions regarding Medicare reimbursement for telemedicine services
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), White House Office
Discussions in support of the Credit Card Competition Act of 2023 (H.R.3881/S.1838)
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office